See What These $15 Billion Managers Have Been Buying
It can pay off to keep an eye on the big guys.3 Investment Strategy Lessons From Vertex's Success
Can you develop an investment strategy based on a biotech success story? Here are 3 lessons that show how it can be done.
The current CEO and president to depart in rapid succession.
Vaccinate Your Portfolio with These 3 Drugmakers
3 drugmakers in the vaccine business that are worth a shot for investors.Here's What This $4 Billion Hedge Fund Has Been Buying
It can pay off to spot which promising companies big investors are favoring.3 Biotechs Still Burning Through Cash
Investors would be wise to know how biotech companies are spending that cash on hand while they develop drugs.
A look back at the biggest stories this week in biotech and what they mean for investors.
3 Horrendous Health-Care Stocks This Week
The Fool looks at 3 horrendous health-care stocks from the past week.
These stocks just rolled over. Can they come back?
Why Dynavax Technologies Shares Imploded
Is this meaningful or just another movement?